Biofrontera AG (ETR:B8FK)
Germany
· Delayed Price · Currency is EUR 2.420
-0.020 (-0.82%)
Apr 29, 2026, 5:35 PM CET
Biofrontera AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 13.19 | 12.18 | 32.25 | 25.74 | 28.79 | Upgrade
|
| Other Revenue | - | - | -0 | - | - | Upgrade
|
| Revenue | 13.19 | 12.18 | 32.25 | 25.74 | 28.79 | Upgrade
|
| Revenue Growth (YoY) | 8.26% | -62.22% | 25.29% | -10.59% | -5.14% | Upgrade
|
| Cost of Revenue | 2.28 | 2.07 | 6.24 | 4.76 | 3.91 | Upgrade
|
| Gross Profit | 10.91 | 10.12 | 26.01 | 20.98 | 24.87 | Upgrade
|
| Selling, General & Admin | 9.7 | 9.5 | 13.38 | 12.26 | 33.75 | Upgrade
|
| Research & Development | 2.23 | 2.2 | 7.85 | 7.13 | 7.01 | Upgrade
|
| Operating Expenses | 11.93 | 11.7 | 21.22 | 19.39 | 40.76 | Upgrade
|
| Operating Income | -1.03 | -1.59 | 4.78 | 1.59 | -15.88 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0.02 | -0.16 | -3.72 | Upgrade
|
| Interest & Investment Income | - | 0.07 | 0.02 | 0 | 0.01 | Upgrade
|
| Earnings From Equity Investments | - | - | -7.26 | -44.17 | 14.73 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -0.01 | -0.68 | 0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.18 | 0.38 | 0.36 | 0.21 | 0.67 | Upgrade
|
| EBT Excluding Unusual Items | -1.22 | -1.15 | -2.13 | -43.21 | -4.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 59.18 | Upgrade
|
| Legal Settlements | - | - | - | - | -19.46 | Upgrade
|
| Pretax Income | -1.22 | -1.15 | -2.13 | -43.21 | 35.68 | Upgrade
|
| Income Tax Expense | 5.72 | -2.49 | -1.76 | 0.96 | 1.83 | Upgrade
|
| Earnings From Continuing Operations | -6.94 | 1.34 | -0.37 | -44.17 | 33.86 | Upgrade
|
| Earnings From Discontinued Operations | 2.98 | -5.69 | - | - | - | Upgrade
|
| Net Income to Company | -3.97 | -4.35 | -0.37 | -44.17 | 33.86 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 4.46 | Upgrade
|
| Net Income | -3.97 | -4.35 | -0.37 | -44.17 | 38.32 | Upgrade
|
| Net Income to Common | -3.97 | -4.35 | -0.37 | -44.17 | 38.32 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 6 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 6 | 3 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | - | 100.00% | 11.02% | 1.34% | 4.68% | Upgrade
|
| EPS (Basic) | -0.65 | -0.72 | -0.12 | -16.14 | 14.53 | Upgrade
|
| EPS (Diluted) | -0.65 | -0.72 | -0.21 | -16.17 | 14.28 | Upgrade
|
| Free Cash Flow | -4.45 | -2.75 | -2.82 | -4.88 | 29.81 | Upgrade
|
| Free Cash Flow Per Share | -0.73 | -0.45 | -0.93 | -1.78 | 11.04 | Upgrade
|
| Gross Margin | 82.71% | 83.03% | 80.64% | 81.52% | 86.41% | Upgrade
|
| Operating Margin | -7.77% | -13.03% | 14.83% | 6.18% | -55.17% | Upgrade
|
| Profit Margin | -30.06% | -35.70% | -1.14% | -171.60% | 133.11% | Upgrade
|
| Free Cash Flow Margin | -33.75% | -22.56% | -8.73% | -18.95% | 103.55% | Upgrade
|
| EBITDA | -0.84 | -1.35 | 4.99 | 1.78 | -15.6 | Upgrade
|
| EBITDA Margin | -6.38% | -11.04% | 15.49% | 6.91% | -54.20% | Upgrade
|
| D&A For EBITDA | 0.18 | 0.24 | 0.21 | 0.19 | 0.28 | Upgrade
|
| EBIT | -1.03 | -1.59 | 4.78 | 1.59 | -15.88 | Upgrade
|
| EBIT Margin | -7.77% | -13.03% | 14.83% | 6.18% | -55.17% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 5.12% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.